Recent next-generation sequencing studies on the pathogenesis of BL have revealed that mutations in the transcription factor TCF3 or its negative regulator ID3 occurred in approximately 70% of sporadic and immunodeficiency-related BL cases and 40% of endemic BL cases. The gene discussed is ID3; the disease is Burkitt lymphoma.